NH

Netrambica Harivanam

Active Director Director DIN 09659669
DIN 09659669 First appointment Jul 2022 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Netrambica Harivanam

Data last updated:

Netrambica Harivanam is a Director at Exome Diagnostics Private Limited (since 2022). The company operates in Non-Profit Organizations.

DIN 09659669
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 01 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Exome Diagnostics Private Limited U85300TG2022PTC164348
Director01 Jul 20222022Active

Board colleagues of Netrambica Harivanam

NameDINCompanyDesignation
Surekha Midde09659670Exome Diagnostics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Exome Diagnostics Private Limited
Premium access

Shareholding and investment profile for Netrambica Harivanam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Netrambica Harivanam

Netrambica Harivanam currently holds 1 directorship: Exome Diagnostics Private Limited (Director, since 01 Jul 2022).

Netrambica Harivanam was first appointed on 01 Jul 2022 as Director at Exome Diagnostics Private Limited.

The current boards of Netrambica Harivanam's companies include Surekha Midde (Exome Diagnostics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available